Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Bacteria or actinomycetales
Patent
1998-08-17
1999-11-23
Chin, Christopher L.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Bacteria or actinomycetales
4242341, 435226, 4352521, 43525233, 435252, 435259, 514 53, 514 54, 536127, A01N 6300, A61K 3902, C12N 112, C12N 120, C12N 964
Patent
active
059895420
ABSTRACT:
The present invention is directed to a method for purifying polysaccharides capable of inducing the production of high titers of opsonic antibodies that kill strains of enterococcal bacteria. In addition, the invention is directed to the antigens produced by this purification method and to vaccines which utilize such antigens.
REFERENCES:
patent: 4242501 (1980-12-01), Cano et al.
patent: 4857512 (1989-08-01), Wagner et al.
patent: 4900677 (1990-02-01), Hewitt
patent: 5292652 (1994-03-01), Dovey et al.
patent: 5472872 (1995-12-01), Mead et al.
patent: 5681736 (1997-10-01), Pace et al.
Wicken, et al., "Structure of Intracellular Teichoic Acids from Group D Streptococci," Biochem J. 87:54-62 (1963).
Huebner Johannes
Madoff Lawrence
Pier Gerald B.
Wang Ying
Brigham and Women's Hospital, Inc.
Chin Christopher L.
Hines Ja-Na A.
Sanzo Michael A.
LandOfFree
Capsular polysaccharides from enterococci does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Capsular polysaccharides from enterococci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Capsular polysaccharides from enterococci will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1218151